MedPath

Hanpoong Pharm.Co., LTD.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Ambroxol Hydrochloride Solution for Inhalation

Product Name
吸入用盐酸氨溴索溶液
Approval Number
H20190041
Approval Date
Jun 8, 2020
NMPA

Terbinafine Hydrochloride Spray

Product Name
采特
Approval Number
国药准字J20150008
Approval Date
Jun 1, 2020
NMPA

Ambroxol Hydrochloride Solution for Inhalation

Product Name
吸入用盐酸氨溴索溶液
Approval Number
国药准字J20190023
Approval Date
Sep 16, 2019
NMPA

Ambroxol Hydrochloride Solution for Inhalation

Product Name
吸入用盐酸氨溴索溶液
Approval Number
H20191018
Approval Date
Aug 16, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.